Université de Montréal

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 marketed ·

Quick facts

Marketed products

Intranasal calcitonin · Endocrinology / Bone metabolism
Intranasal calcitonin is a peptide hormone that binds to calcitonin receptors on osteoclasts to inhibit bone resorption and increase bone mineral density.

Phase 2 pipeline

Alesse · Other

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Université de Montréal portfolio CI brief
Université de Montréal pipeline updates RSS

Frequently asked questions about Université de Montréal

What are Université de Montréal's marketed drugs?

Top marketed products include Intranasal calcitonin.

Intranasal calcitonin · Endocrinology / Bone metabolism
Sector hub: All tracked pharma companies